Reported mechanistic benefits of inhibiting the action of BRD4 in hyperglycaemia conditions are associated with increased caveolin‐1 expression [95], reduced AKT phosphorylation [96] and most recently, activation of PINK1/Parkin‐mediated mitophagy [94] (Figure 3). This evidence concerns the gene AKT1 and Hyperglycemia.